{
  "trial_id": "NCT03647631",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Thickness greater than or equal to 5mm",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "mitoses per 10 high-power field greater than or equal to 7",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Immunohistochemical (IHC) analysis positive for :carcinoembryonic antigen (CEA)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "cytokeratin (CK) 5,7 and epithelial membrane antigen (EMA).",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Informed consent obtained for the SNLB procedure.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [],
  "notes": "Patient has RRMS and is under treatment, but no exclusion criteria mentioned.",
  "_meta": {
    "topic_id": "37",
    "trial_id": "NCT03647631",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}